Sun Yat-sen University

This study tested whether adding a low-dose chemotherapy drug (capecitabine) to standard hormone therapy (aromatase inhibitor) helps women with a common type of advanced breast cancer live longer without the disease getting worse. The trial included 263 women whose cancer had spr…

This study looked at 74 adults with liver cancer that could not be removed at first. After initial treatments like chemoembolization, targeted therapy, and immunotherapy, some patients had a complete response (no visible cancer). The study compared two approaches: surgery to remo…

This study tested whether adding a liver-directed chemotherapy (HAIC) to a standard drug combination (Gemox, lenvatinib, and toripalimab) could help people with advanced bile duct cancer live longer without the disease getting worse. 96 adults whose cancer could not be removed by…

This study tested a combination of three drugs—high-dose furmonertinib, bevacizumab, and chemotherapy injected into the spine—in 46 people with a specific type of lung cancer (EGFR-mutated) that had spread to the lining of the brain and spinal cord. The goal was to see if this tr…

This early-phase study tested a combination of two drugs, cetuximab and capecitabine, given every three weeks as a maintenance treatment for people with a specific type of metastatic colorectal cancer (KRAS/BRAF wild-type). The main goals were to find a safe dose and understand h…

This study tested a combination of an immunotherapy drug (anti-PD-1) and a chemotherapy drug (albumin-bound paclitaxel) in 27 people whose cervical cancer had returned or worsened after standard treatment. The goal was to see if the combination could shrink tumors and help people…

This study tested whether giving a combination of two drugs (cadonilimab and lenvatinib) before surgery could shrink kidney tumors enough to allow a partial, kidney-sparing operation instead of full removal. It included 39 adults with clear cell kidney cancer whose tumors were la…

This study tested a combination of two drugs, apatinib and etoposide, in 35 women with ovarian cancer that no longer responded to standard platinum chemotherapy. The goal was to see if the combination could shrink tumors or slow cancer growth. Participants took the drugs by mouth…

This study tested a combination of an immunotherapy drug (durvalumab) and chemotherapy delivered directly to the liver in 30 people with advanced liver cancer that had spread into the main portal vein. The goal was to see if this approach could help patients live longer and contr…

This study looked at 200 people with advanced liver cancer whose first treatment stopped working. Researchers compared two different drug combinations to see which worked better and was safer. The goal is to help doctors choose the best second-line treatment for these patients.

This study tested whether neurotropin can prevent or reduce nerve damage caused by the chemotherapy drug oxaliplatin in people with stage II or III colorectal cancer. The trial involved 333 participants who were randomly assigned to receive either neurotropin or a placebo during …

This study tested whether two different sonic toothbrushes could reduce surface stains on teeth better than a standard manual toothbrush. Over 8 weeks, 129 adults brushed as usual and had their tooth stains measured. The goal was to see which brush type led to less stain buildup.

This study looked at two ways to deliver pain medicine through an epidural after video-assisted lung surgery. One method gives a steady drip, the other gives small bursts on a timer. The goal was to see which helps patients recover better. 252 adults took part, and researchers me…

This study looked at 103 previous studies to compare the nutrients in breast milk from mothers who gave birth early (preterm) versus full-term. Researchers measured energy, protein, fat, and other components to see if they differ. No treatments or interventions were given to part…

This study looked at how a mother's nutrition during and after pregnancy affects her blood sugar levels and her child's health. Over 1,100 pregnant women in Guangzhou took part. Researchers measured mothers' glucose and insulin, and followed children's growth, brain development, …

This study used artificial intelligence to analyze data from 7,000 liver cancer patients. The goal was to create a tool that helps doctors predict which treatments—like surgery or medication—will work best for each person. The AI model looks at patient information to guide person…